Modig Berndt 4
4 · Axovant Sciences Ltd. · Filed Jan 3, 2018
Insider Transaction Report
Form 4
Modig Berndt
Director
Transactions
- Exercise/Conversion
Common Stock
2017-12-29$0.90/sh+77,914$70,123→ 77,914 total - Exercise/Conversion
Stock Option (right to buy)
2017-12-29−77,914→ 7,086 totalExercise: $0.90Exp: 2025-03-17→ Common Stock (77,914 underlying)
Footnotes (1)
- [F1]This option vests over a period of three years, with one third of the common shares underlying the option having vested on March 18, 2016 and the remainder vesting in eight equal quarterly installments thereafter.